| Teresa A Faxas, MD | |
|
10000 W Sample Rd, Coral Springs, FL 33065-3936 | |
| (954) 346-8800 | |
| Not Available |
| Full Name | Teresa A Faxas |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 10000 W Sample Rd, Coral Springs, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427261544 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | ME60817 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Teresa A Faxas, MD 10000 W Sample Rd, Coral Springs, FL 33065-3936 Ph: (954) 346-8800 | Teresa A Faxas, MD 10000 W Sample Rd, Coral Springs, FL 33065-3936 Ph: (954) 346-8800 |
News Archive
Forest Laboratories announced today its agreement to acquire additional rights to NXL 104, which amends the terms of its prior agreement with Novexel covering the combination of NXL 104 with ceftaroline and adds additional rights to the combination of ceftazidime and NXL 104, through a transaction with AstraZeneca executed immediately following AstraZeneca's announced acquisition of Novexel, S.A.
Reporting for Kaiser Health News, in collaboration with The Washington Post, Susan Jaffe writes: "Concerned that a growing number of seniors have been unexpectedly forced to pay thousands of dollars for nursing home care after a stay in a hospital, Medicare has launched a pilot project to test whether relaxing its hospital payment rules could help beneficiaries".
Biodel Inc. today reported results of preclinical tests which demonstrated the potential of the company's glucose-regulated or "smart" basal insulin product candidate, BIOD620, to release insulin proportionally in response to changing glucose conditions. In an oral presentation today at the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland, Oregon, Nandini Kashyap, director of novel drug delivery at Biodel, described results of in vitro and in vivo studies with diabetic pigs which compared the use of BIOD620 to Lantus® (insulin glargine).
Research carried out at the Hebrew University of Jerusalem has provided the first proof of molecular risk factors leading to type 2 diabetes, providing an "early warning" sign that could lead to new approaches to treating this and other human disease conditions.
› Verified 5 days ago
Steven Restler, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9120a Wiles Rd, Coral Springs, FL 33067 Phone: 954-341-0074 Fax: 954-345-3474 | |
Michelle T Snyder, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9750 Nw 33rd St Ste 101, Coral Springs, FL 33065 Phone: 954-752-9220 Fax: 954-752-1549 | |
Dr. Shawnette Simone Saddler, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 9750 Nw 33rd St Ste 202, Coral Springs, FL 33065 Phone: 954-320-3390 Fax: 954-340-4557 | |
Dr. Neelam Seth, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2929 N University Dr, Suite 201, Coral Springs, FL 33065 Phone: 954-510-7900 Fax: 954-510-7999 | |
Dr. Dale Garber, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5810 Coral Ridge Dr Ste 300, Coral Springs, FL 33076 Phone: 954-414-7700 | |
Ileana De La Sota, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9120 -a Wiles Rd, Coral Springs, FL 33067 Phone: 954-341-0074 Fax: 954-345-3474 | |
Dr. Lorne Katz, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9750 Nw 33rd St, 101, Coral Springs, FL 33065 Phone: 954-752-9220 Fax: 954-752-1549 |